Safety and Effectiveness of PRX-08066 in Patients With Pulmonary Hypertension and Chronic Obstructive Pulmonary Disease

A Multinational, Multicenter, Study to Assess the Efficacy and Safety of BPS-314d-MR in Subjects With Pulmonary Arterial Hypertension Currently Receiving Treatment With an Endothelin Receptor Antagonist and/or a Phosphodiesterase-5 Inhibitor

NCT01458236 ·Status: WITHDRAWN ·Phase: PHASE3

A Study to Learn About the Study Medicine Called PF-07868489 in Healthy Adult People and in People With Pulmonary Arterial Hypertension

NCT06137742 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2

Effects of Ventavis in Patients With Pulmonary Hypertension (PH) Secondary to Chronic Obstructive Pulmonary Disease (COPD)

NCT01437878 ·Status: TERMINATED ·Phase: PHASE2

Inhaled Iloprost in Adults With Abnormal Pulmonary Pressure and Associated With Idiopathic Pulmonary Fibrosis

NCT00109681 ·Status: COMPLETED ·Phase: PHASE2

Comparison of Vasodilator Response of Inhaled Epoprostenol and Inhaled Nitric Oxide

NCT04231084 ·Status: COMPLETED ·Phase: PHASE4

A Study to Assess Pulsed Inhaled Nitric Oxide in Subjects With Pulmonary Hypertension Associated With Pulmonary Fibrosis

NCT05747508 ·Status: UNKNOWN ·Phase: PHASE2

Clinical Study of Pulsed, Inhaled Nitric Oxide Versus Placebo in Symptomatic Subjects With PAH

NCT02725372 ·Status: TERMINATED ·Phase: PHASE3

Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD

NCT01728220 ·Status: COMPLETED ·Phase: PHASE2

Inhaled Treprostinil in Participants With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD)

NCT03794583 ·Status: TERMINATED ·Phase: PHASE3

Frespaciguat (MK-5475) INSIGNIA-PH-COPD: A Study of the Efficacy and Safety of Frespaciguat (an Inhaled sGC Stimulator) in Adults With PH-COPD

NCT05612035 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Efficacy and Safety of Seralutinib in Adult Subjects With PAH (PROSERA)

NCT05934526 ·Status: COMPLETED ·Phase: PHASE3

A Study to Assess Pulsed Inhaled Nitric Oxide in Subjects With Pulmonary Fibrosis at Risk for Pulmonary Hypertension

NCT03267108 ·Status: TERMINATED ·Phase: PHASE3

Phase IV Study of Chronic Infusional Epoprostenol for Severe Primary Pulmonary Hypertension

NCT00004754 ·Status: COMPLETED ·Phase: PHASE4

PRIMEx - A Study of 2 Doses of Oral CXA-10 in Pulmonary Arterial Hypertension (PAH)

NCT03449524 ·Status: TERMINATED ·Phase: PHASE2

3 Part Study to Assess Inhaled Nitric Oxide on Functional Pulmonary Imaging in Subj. Pulmonary Hypertension Associated w/ COPD and IPF

NCT02267655 ·Status: COMPLETED ·Phase: PHASE1

Acute Effects of rhBNP in Patients With PH Associated With Acute Exacerbation of Chronic Pulmonary Disease

NCT02742909 ·Status: COMPLETED ·Phase: PHASE4

Safety, Pharmacokinetics and Efficacy Study of QCC374 in PAH Patients

NCT02927366 ·Status: TERMINATED ·Phase: PHASE2

Safety and Tolerability of Inhaled Treprostinil in Adult PH Due to COPD

NCT03012646 ·Status: WITHDRAWN ·Phase: PHASE2

Bardoxolone Methyl Evaluation in Patients With Pulmonary Hypertension (PH) - LARIAT

NCT02036970 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of Oral Bosentan in Patients With Idiopathic Pulmonary Fibrosis

NCT00071461 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Inhaled Nitric Oxide/INOpulse DS for Pulmonary Arterial Hypertension (PAH)

NCT01457781 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy of Inhaled Treprostinil in Patients With PAH

NCT01557647 ·Status: WITHDRAWN ·Phase: PHASE3

A Research Study To Assess The Effectiveness And Safety Of Different Doses Of Oral PF-00489791 In The Treatment Of Adult Patients With Pulmonary Arterial Hypertension

NCT00853112 ·Status: TERMINATED ·Phase: PHASE2

Single Dose Study in Patients With Chronic Obstructive Pulmonary Disease (COPD) Associated Pulmonary Hypertension.

NCT00640315 ·Status: COMPLETED ·Phase: PHASE1

A Study of TX000045 in Patients With Pulmonary Hypertension Secondary to Heart Failure With Preserved Ejection Fraction (the APEX Study)

NCT06616974 ·Status: RECRUITING ·Phase: PHASE2